Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Jiang, Shibo ; He, Yuxian ; Liu, Shuwen
Jiang, Shibo ; He, Yuxian ; Liu, Shuwen Less -
Description:
Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it is easy to generate; however, safety is the main concern. The spike (S) protein of SARS-CoV is the major inducer of neutralizing antibodies, and the receptor-binding domain (RBD) in the S1 subunit of S protein contains multiple conformational neutralizing epitopes. This suggests that recombinant proteins containing RBD and vectors encoding the RBD sequence can be used to develop safe and effective SARS vaccines.
Subjects:
[+]
Epitopes Humans Membrane Glycoproteins Neutralizing Epitone Receptor-binding Domain SARS SARS-CoV SARS Virus Severe Acute Respiratory Syndrome Spike Glycoprotein, Coronavirus Spike Protein Synopsis Vaccine Vaccines, Inactivated Viral Envelope Proteins Viral Vaccines
Source:
Emerg Infect Dis. 11(7):1016-1020.
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:7a028247701c437d3cb38bb71bfb4ab4f3886215664a7e0ee49875191d40ad1a
Download URL:
https://stacks.cdc.gov/view/cdc/15859/cdc_15859_DS1.pdf
File Type:

Supporting Files

• 	05-0219-F1.gif	gif
  	05-0219-F1.jpg	jpeg
  	05-0219-F2.gif	gif
  	05-0219-F2.jpg	jpeg
  	05-0219.nxml	txt
  	license.txt	txt

More +